NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 362 filers reported holding NOVOCURE LTD in Q2 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $477,184 | -12.6% | 29,547 | +527.7% | 0.00% | 0.0% |
Q3 2021 | $546,000 | -86.1% | 4,707 | -73.4% | 0.00% | -85.7% |
Q2 2021 | $3,922,000 | +23.2% | 17,680 | -27.4% | 0.01% | +40.0% |
Q1 2021 | $3,184,000 | +71.6% | 24,349 | +127.0% | 0.01% | +66.7% |
Q4 2020 | $1,856,000 | -61.8% | 10,727 | -86.9% | 0.00% | -62.5% |
Q2 2020 | $4,863,000 | -2.1% | 82,003 | +11.2% | 0.01% | 0.0% |
Q1 2020 | $4,966,000 | +54.8% | 73,751 | +93.8% | 0.01% | +100.0% |
Q4 2019 | $3,208,000 | +6.9% | 38,065 | -5.2% | 0.00% | 0.0% |
Q3 2019 | $3,002,000 | +48.8% | 40,138 | +25.8% | 0.00% | +100.0% |
Q2 2019 | $2,017,000 | +8.6% | 31,899 | -17.3% | 0.00% | 0.0% |
Q1 2019 | $1,857,000 | +29.5% | 38,557 | -10.0% | 0.00% | 0.0% |
Q4 2018 | $1,434,000 | -86.1% | 42,818 | -78.2% | 0.00% | -80.0% |
Q3 2018 | $10,308,000 | +43.7% | 196,711 | -14.1% | 0.01% | +42.9% |
Q2 2018 | $7,171,000 | +86.4% | 229,110 | +29.8% | 0.01% | +75.0% |
Q1 2018 | $3,847,000 | +14.9% | 176,461 | +6.4% | 0.00% | 0.0% |
Q4 2017 | $3,349,000 | +561.9% | 165,796 | +550.1% | 0.00% | +300.0% |
Q3 2017 | $506,000 | – | 25,504 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 470,884 | $39,681,000 | 20.12% |
HARTLINE INVESTMENT CORP/ | 330,672 | $27,866,000 | 5.97% |
MORGAN JESS S & CO INC | 52,889 | $4,457,000 | 4.37% |
Darsana Capital Partners LP | 1,350,000 | $113,765,000 | 3.88% |
Rhenman & Partners Asset Management AB | 350,000 | $29,495,000 | 3.23% |
COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $843,000 | 2.55% |
Taylor Frigon Capital Management LLC | 38,073 | $3,208,000 | 2.21% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,500 | $2,991,000 | 1.08% |
Granite Investment Partners, LLC | 261,315 | $22,021,000 | 1.04% |
Nicholas Investment Partners, LP | 85,835 | $7,233,000 | 0.74% |